Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book
More to follow. Follow Allison Gatlin on X/Twitter at @AGatlin_IBD. YOU MAY ALSO LIKE: TESLA WATCH: Elon Musk Pay Deal In Focus Vertex stock dipped late Monday after the biotech company reported adjusted earnings of 3.08 billion in third-quarter sales. On average, analysts polled by FactSet expected Vertex Pharmaceuticals (VRTX) to earn 3.06 billion in sales. In the year-earlier period, Vertex earned 2.77 billion in sales. The biotech giant rai ...